For procurement managers in the pharmaceutical and chemical industries, securing a reliable supply of high-quality intermediates like (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride (CAS 331763-59-8) is a strategic imperative. This compound, characterized by its off-white to white solid or powder appearance and typically 97% purity, is crucial for various research and manufacturing processes, particularly in the development of neurological treatments.

When considering where to buy this specific chemical, focusing on established manufacturers and suppliers, especially those based in China, can offer significant advantages. China's robust chemical manufacturing sector provides access to competitive pricing and substantial production capacities, making it an attractive sourcing region for bulk orders. Procurement managers often initiate their search by looking for suppliers who can provide consistent quality and timely delivery.

The primary utility of (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride in the R&D landscape is its function as a GABA receptor agonist. This pharmacological property makes it a sought-after compound for companies involved in drug discovery, particularly for conditions affecting the central nervous system and those involving muscle spasticity. The molecular details, such as its formula C10H13Cl2NO2 and molecular weight of 250.12, are critical for precise application and are typically provided by reliable manufacturers.

When evaluating potential suppliers, key considerations for procurement managers include the supplier's track record, their ability to provide detailed specifications and certifications (like CoA), and their pricing structure for various order volumes. For companies planning large-scale production, securing a long-term supply agreement with a trusted manufacturer is essential for supply chain stability.

Furthermore, it’s important to engage with suppliers who understand the stringent quality requirements of the pharmaceutical industry. This includes not only the purity of the compound but also its enantiomeric purity, as the biological activity of chiral molecules can be highly dependent on their stereochemistry. A good supplier will be transparent about these aspects.

In conclusion, for procurement managers tasked with sourcing (R)-3-Amino-4-(4-chlorophenyl)butyric Acid Hydrochloride, a strategic approach focusing on identifying reputable manufacturers, comparing prices, and ensuring quality compliance is key. By leveraging the strengths of global suppliers, particularly those in China, companies can secure this vital pharmaceutical intermediate effectively.